FNY Investment Advisers’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,575
| Closed | -$514K | – | 851 |
|
|
2024
Q2 | $514K | Buy |
+12,575
| New | +$514K | 0.35% | 55 |
|
|
2024
Q1 | – | Sell |
-8,000
| Closed | -$339K | – | 871 |
|
|
2023
Q4 | $339K | Buy |
+8,000
| New | +$339K | 0.38% | 52 |
|
|
2022
Q1 | – | Sell |
-15
| Closed | – | – | 927 |
|
|
2021
Q4 | $0 | Buy |
+15
| New | – | ﹤0.01% | 810 |
|
|
2020
Q4 | – | Sell |
-5,166
| Closed | -$53K | – | 884 |
|
|
2020
Q3 | $53K | Buy |
+5,166
| New | +$53K | 0.02% | 242 |
|